Aging and metabolic dysfunction-associated steatotic liver disease: a bidirectional relationship.
10.1007/s11684-025-1133-7
- Author:
Chen CHEN
1
;
Lin WANG
2
,
3
Author Information
1. Department of Hepatobiliary Surgery, Xi-Jing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
2. Department of Hepatobiliary Surgery, Xi-Jing Hospital, Fourth Military Medical University, Xi'an, 710032, China. fierywang@
3. com.
- Publication Type:Review
- Keywords:
aging;
cell senescence;
metabolic dysfunction-associated steatohepatitis;
metabolic dysfunction-associated steatotic liver disease
- MeSH:
Humans;
Aging/physiology*;
Fatty Liver/metabolism*;
Liver/pathology*;
Cellular Senescence;
Animals
- From:
Frontiers of Medicine
2025;19(3):427-438
- CountryChina
- Language:English
-
Abstract:
In recent years, aging and cellular senescence have triggered an increased interest in corresponding research fields. Evidence shows that the complex aging process is involved in the development of many chronic liver diseases, such as metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH). In fact, aging has a tremendous effect on the liver, leading to a gradual decline in the metabolism, detoxification and immune functions of the liver, which in turn increases the risk of liver disease. These changes can be based on the aging of liver cells (hepatocytes, liver sinusoidal endothelial cells, hepatic stellate cells, and Kupffer cells). Similarly, patients with liver diseases exhibit increases in the aging phenotype and aging cells, often manifesting as faster physical functional decline, which is closely related to the promoting effect of liver disease on aging. This review summarizes the interplay between MASLD/MASH development and aging, aiming to reveal the complex relationships that exacerbate one another. Moreover, the corresponding schemes for delaying aging or treating diseases are discussed to provide a basis for the development of effective prevention and treatment strategies in the future.
